Market Overview:
The global intrauterine contraceptive device market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing awareness about contraception, rising prevalence of sexually transmitted infections (STIs), and technological advancements in intrauterine contraceptive devices (IUDs). Based on type, the hormonal IUCD segment is expected to account for the largest share of the global intrauterine contraceptive device market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. The growth in this segment can be attributed to factors such as increasing awareness about contraception and technological advancements in hormonal IUCDs. Based on application, hospitals are expected to account for the largest share of the global intrauterine contraceptive device market in 2018. This segment is also projected to grow at a higher CAGR than other segments duringthe forecast period.
Product Definition:
An intrauterine contraceptive device (IUD) is a small, T-shaped piece of plastic or metal that is inserted into the uterus to prevent pregnancy. There are two types of IUDs: copper and hormonal. Both types work by slowly releasing hormones or copper into the uterus. This prevents the sperm from fertilizing an egg. The IUD can also be used to treat heavy periods.
Hormonal IUCD:
Hormonal Intrauterine Contraceptive Devices (IUDs) are a group of birth control methods that include both reversible and irreversible devices. The IUD market is one of the fastest-growing markets in women's healthcare, with an estimated annual growth rate of 6% - 7%. This can be attributed to the fact that they are one of the most effective birth control methods available today.
Copper IUCD:
Intrauterine contraceptive device (IUD) is a modern day birth control method that works by preventing implantation within the uterus. It does not protect against pregnancy but rather prevents the fertilized egg from attaching to the uterus. Copper IUD is one such effective and safe method of birth control available in today’s market.
The copper IUD as a Contraceptive Technology was first approved by the U.
Application Insights:
Based on application, the global IUD market has been segmented into hospitals and surgical centers. The hospital segment dominated the overall market in terms of revenue in 2017 due to factors such as rising number of childbirths and increasing prevalence of female reproductive disorders. According to WHO, around 1.1 billion women above 40 years across the globe have undergone some form of Fertility Awareness Method (FAM) or Natural Family Planning (NFP). This is expected to drive demand for IUDs over the forecast period.
The surgical center segment is anticipated to witness a CAGR exceeding 9% from 2018 to 2030 owing to factors such as growing awareness about reversible contraceptive methods among physicians and an increase in number of laparoscopic surgeries being performed worldwide.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position during the forecast period. This can be attributed to increasing awareness about contraceptive measures, rising disposable income of women, and availability of effective methods. China has one of the largest markets for IUDs globally as a result of high unmet need among women regarding contraception. The government offers various programs for family planning and sex education to encourage people against accidental pregnancies.
Europe held a significant share in global intrauterine contraceptive device market due to growing population, aging population, increase in unplanned pregnancies & abortions along with rise in sexually transmitted infections including HIV/AIDS that are associated with unprotected sex across Europe countries. Rise in demand for long-term contraceptives is anticipated to drive growth over the forecast period as well as several European countries do not allow sales or distribution of these devices within their own country borders thus creating an international market for IUDs or other Intra Uterine Devices (IUS).
Growth Factors:
- Increasing awareness about contraception and intrauterine contraceptive devices (IUDs) among women of childbearing age
- Growing number of manufacturers and distributors of IUDs worldwide
- Rising demand for long-term reversible contraception methods
- Availability of government funding for purchase of IUDs by women in developing countries
- Technological advancements in the design and manufacturing of IUDs
Scope Of The Report
Report Attributes
Report Details
Report Title
Intrauterine Contraceptive Device Market Research Report
By Type
Hormonal IUCD, Copper IUCD
By Application
Hospitals, Surgical Centers
By Companies
Bayer HealthCare, Medisafe Distribution, Teva Pharmaceutical Industrie, Medicines360, Pace Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Intrauterine Contraceptive Device Market Report Segments:
The global Intrauterine Contraceptive Device market is segmented on the basis of:
Types
Hormonal IUCD, Copper IUCD
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer HealthCare
- Medisafe Distribution
- Teva Pharmaceutical Industrie
- Medicines360
- Pace Pharmaceuticals
Highlights of The Intrauterine Contraceptive Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hormonal IUCD
- Copper IUCD
- By Application:
- Hospitals
- Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intrauterine Contraceptive Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intrauterine contraceptive devices (IUDs) are a type of birth control that is inserted into the uterus by a doctor. IUDs work by preventing sperm from entering the uterus and fertilizing an egg. IUDs may also prevent pregnancy in cases of rape or when a woman does not have regular menstrual cycles.
Some of the major players in the intrauterine contraceptive device market are Bayer HealthCare, Medisafe Distribution, Teva Pharmaceutical Industrie, Medicines360, Pace Pharmaceuticals.
The intrauterine contraceptive device market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intrauterine Contraceptive Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intrauterine Contraceptive Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intrauterine Contraceptive Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intrauterine Contraceptive Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intrauterine Contraceptive Device Market Size & Forecast, 2018-2028
4.5.1 Intrauterine Contraceptive Device Market Size and Y-o-Y Growth
4.5.2 Intrauterine Contraceptive Device Market Absolute $ Opportunity
Chapter 5 Global Intrauterine Contraceptive Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Intrauterine Contraceptive Device Market Size Forecast by Type
5.2.1 Hormonal IUCD
5.2.2 Copper IUCD
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Intrauterine Contraceptive Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Intrauterine Contraceptive Device Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intrauterine Contraceptive Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intrauterine Contraceptive Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Intrauterine Contraceptive Device Analysis and Forecast
9.1 Introduction
9.2 North America Intrauterine Contraceptive Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Intrauterine Contraceptive Device Market Size Forecast by Type
9.6.1 Hormonal IUCD
9.6.2 Copper IUCD
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Intrauterine Contraceptive Device Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Intrauterine Contraceptive Device Analysis and Forecast
10.1 Introduction
10.2 Europe Intrauterine Contraceptive Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Intrauterine Contraceptive Device Market Size Forecast by Type
10.6.1 Hormonal IUCD
10.6.2 Copper IUCD
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Intrauterine Contraceptive Device Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Intrauterine Contraceptive Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Intrauterine Contraceptive Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Intrauterine Contraceptive Device Market Size Forecast by Type
11.6.1 Hormonal IUCD
11.6.2 Copper IUCD
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Intrauterine Contraceptive Device Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Intrauterine Contraceptive Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Intrauterine Contraceptive Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Intrauterine Contraceptive Device Market Size Forecast by Type
12.6.1 Hormonal IUCD
12.6.2 Copper IUCD
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Intrauterine Contraceptive Device Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Intrauterine Contraceptive Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Intrauterine Contraceptive Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Intrauterine Contraceptive Device Market Size Forecast by Type
13.6.1 Hormonal IUCD
13.6.2 Copper IUCD
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Intrauterine Contraceptive Device Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intrauterine Contraceptive Device Market: Competitive Dashboard
14.2 Global Intrauterine Contraceptive Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer HealthCare
14.3.2 Medisafe Distribution
14.3.3 Teva Pharmaceutical Industrie
14.3.4 Medicines360
14.3.5 Pace Pharmaceuticals
